Benedict Financial Advisors Inc. Has $10.83 Million Holdings in Johnson & Johnson (NYSE:JNJ)
Benedict Financial Advisors Inc. Has $10.83 Million Holdings in Johnson & Johnson (NYSE:JNJ)
Johnson & Johnson (NYSE:JNJ – Get Rating) last released its earnings results on Tuesday, October 18th. The company reported $2.55 earnings per share for the quarter, beating the consensus estimate of $2.49 by $0.06. Johnson & Johnson had a return on equity of 35.32% and a net margin of 19.95%. The firm had revenue of $23.79 billion for the quarter, compared to analyst estimates of $23.44 billion. During the same quarter in the prior year, the firm posted $2.60 earnings per share. The company's quarterly revenue was up 1.9% on a year-over-year basis. As a group, research analysts anticipate that Johnson & Johnson will post 10.05 earnings per share for the current year. Benedict Financial Advisors Inc. lifted its position in Johnson & Johnson (NYSE:JNJ – Get Rating) by 2.7% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 61,001 shares of the company's stock after buying an additional 1,605 shares during the quarter. Johnson & Johnson comprises 3.2% of Benedict Financial Advisors Inc.'s investment portfolio, making the stock its 3rd largest holding. Benedict Financial Advisors Inc.'s holdings in Johnson & Johnson were worth $10,828,000 at the end of the most recent reporting period.
據本尼迪克特金融顧問公司在最近提交給美國證券交易委員會的13F文件中稱，該公司在第二季度將其在強生(紐約證券交易所代碼：JNJ-GET評級)的持倉上調了2.7%。該機構投資者在本季度額外購買了1,605股後，持有該公司61,001股股票。強生在本尼迪克特金融顧問公司的投資組合中佔3.2%，是其第三大持股。截至最近一次報告期結束時，本尼迪克特金融顧問公司持有的強生股份價值10,828,000美元。
Several other large investors have also made changes to their positions in the company. Howard Financial Services LTD. raised its stake in shares of Johnson & Johnson by 2.1% in the first quarter. Howard Financial Services LTD. now owns 2,757 shares of the company's stock valued at $489,000 after purchasing an additional 57 shares in the last quarter. American Financial Advisors LLC raised its stake in shares of Johnson & Johnson by 2.1% in the first quarter. American Financial Advisors LLC now owns 2,715 shares of the company's stock valued at $481,000 after purchasing an additional 57 shares in the last quarter. Taylor & Morgan Wealth Management LLC grew its position in Johnson & Johnson by 1.6% in the second quarter. Taylor & Morgan Wealth Management LLC now owns 3,580 shares of the company's stock valued at $635,000 after acquiring an additional 57 shares during the period. Kwmg LLC grew its position in Johnson & Johnson by 2.6% in the first quarter. Kwmg LLC now owns 2,354 shares of the company's stock valued at $417,000 after acquiring an additional 59 shares during the period. Finally, Circle Wealth Management LLC grew its position in Johnson & Johnson by 0.5% in the first quarter. Circle Wealth Management LLC now owns 11,326 shares of the company's stock valued at $2,007,000 after acquiring an additional 59 shares during the period. Institutional investors own 68.59% of the company's stock.
其他幾家大型投資者也對他們在該公司的頭寸進行了調整。霍華德金融服務有限公司第一季增持強生股份2.1%.霍華德金融服務有限公司在上個季度又購買了57股後，現在擁有2,757股該公司股票，價值48.9萬美元。美國金融顧問公司第一季度增持強生股份2.1%.American Financial Advisors LLC現在持有該公司2,715股股票，價值481,000美元，上個季度又購買了57股。泰勒·摩根財富管理有限責任公司第二季度增持了強生的股份，增幅為1.6%。Taylor&Morgan Wealth Management LLC現在擁有3580股該公司股票，價值63.5萬美元，在此期間又購買了57股。第一季度，Kumg LLC在強生的持倉增加了2.6%。在此期間收購了另外59股後，Kumg LLC現在擁有2354股該公司的股票，價值41.7萬美元。最後，圈子財富管理有限責任公司在第一季度對強生的持倉增長了0.5%。Circle Wealth Management LLC現在擁有11,326股該公司的股票，價值2,007,000美元，在此期間又購買了59股。機構投資者持有該公司68.59%的股份。
Analyst Ratings Changes
分析師評級發生變化
A number of brokerages have weighed in on JNJ. Sanford C. Bernstein lowered their price target on Johnson & Johnson from $194.00 to $190.00 in a research report on Wednesday, October 19th. UBS Group lowered their price target on Johnson & Johnson from $185.00 to $180.00 in a research report on Thursday, July 21st. StockNews.com began coverage on Johnson & Johnson in a research report on Wednesday, October 12th. They issued a "strong-buy" rating on the stock. Atlantic Securities decreased their target price on Johnson & Johnson from $165.00 to $160.00 and set a "neutral" rating on the stock in a report on Wednesday, October 19th. Finally, Raymond James decreased their target price on Johnson & Johnson from $192.00 to $185.00 and set an "outperform" rating on the stock in a report on Wednesday, October 19th. Six analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Johnson & Johnson has an average rating of "Moderate Buy" and an average price target of $184.25.
許多券商都加入了對JNJ的看法。桑福德·伯恩斯坦在10月19日星期三的一份研究報告中將強生的目標價從194.00美元下調至190.00美元。7月21日，瑞銀集團在一份研究報告中將強生的目標價從185.00美元下調至180.00美元。10月12日，星期三，斯托克新聞網開始在一份研究報告中對強生進行報道。他們對該股的評級為“強力買入”。大西洋證券在10月19日(週三)的一份報告中將強生的目標價從165.00美元下調至160.00美元，並將該股的評級定為“中性”。最後，雷蒙德·詹姆斯在10月19日(週三)的一份報告中將強生的目標價從192.00美元下調至185.00美元，並對該股設定了“跑贏大盤”的評級。六位分析師對該股的評級為持有，五位分析師發佈了買入評級，一位分析師對該股給予了強烈的買入評級。根據MarketBeat.com的數據，強生的平均評級為“中等買入”，平均目標價為184.25美元。
Johnson & Johnson Price Performance
強生性價比
Johnson & Johnson (NYSE:JNJ – Get Rating) last released its earnings results on Tuesday, October 18th. The company reported $2.55 earnings per share for the quarter, beating the consensus estimate of $2.49 by $0.06. Johnson & Johnson had a return on equity of 35.32% and a net margin of 19.95%. The firm had revenue of $23.79 billion for the quarter, compared to analyst estimates of $23.44 billion. During the same quarter in the prior year, the firm posted $2.60 earnings per share. The company's quarterly revenue was up 1.9% on a year-over-year basis. As a group, research analysts anticipate that Johnson & Johnson will post 10.05 earnings per share for the current year.
強生(紐約證券交易所代碼：JNJ-GET Rating)最近一次發佈收益報告是在10月18日(星期二)。該公司公佈本季度每股收益為2.55美元，比普遍預期的2.49美元高出0.06美元。強生的股本回報率為35.32%，淨利潤率為19.95%。該公司本季度營收為237.9億美元，而分析師預期為234.4億美元。去年同期，該公司公佈的每股收益為2.60美元。該公司季度營收同比增長1.9%。作為一個整體，研究分析師預計強生本年度每股收益將為10.05%。
Johnson & Johnson Dividend Announcement
強生分紅公告
The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 6th. Shareholders of record on Tuesday, November 22nd will be paid a $1.13 dividend. This represents a $4.52 annualized dividend and a yield of 2.69%. The ex-dividend date is Monday, November 21st. Johnson & Johnson's payout ratio is 62.95%.
該業務最近還宣佈了季度股息，將於12月6日(星期二)支付。11月22日(星期二)登記在冊的股東將獲得1.13美元的股息。這意味着年化股息為4.52美元，收益率為2.69%。除息日期為11月21日(星期一)。強生的派息率為62.95%.
Johnson & Johnson announced that its board has approved a share buyback program on Wednesday, September 14th that allows the company to buyback $5.00 billion in outstanding shares. This buyback authorization allows the company to reacquire up to 1.2% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's board of directors believes its stock is undervalued.
強生宣佈，董事會已於9月14日(星期三)批准了一項股票回購計劃，允許公司回購50億美元的流通股。這項回購授權允許該公司通過公開市場購買重新獲得高達1.2%的股份。股票回購計劃通常是公司董事會認為其股票被低估的跡象。
Insider Buying and Selling at Johnson & Johnson
強生的內幕買賣
In other Johnson & Johnson news, VP Peter Fasolo sold 22,864 shares of the stock in a transaction dated Wednesday, October 19th. The stock was sold at an average price of $164.50, for a total value of $3,761,128.00. Following the transaction, the vice president now owns 114,676 shares of the company's stock, valued at $18,864,202. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.35% of the company's stock.
在強生的另一則消息中，副總裁彼得·法索洛在10月19日星期三的交易中出售了22,864股該股。這隻股票的平均售價為164.50美元，總價值為3761,128.00美元。交易完成後，副總經理總裁現在持有該公司114,676股股票，價值18,864,202美元。這筆交易是在提交給美國證券交易委員會的一份法律文件中披露的，該文件可在這個環節。內部人士持有該公司0.35%的股份。
Johnson & Johnson Profile
強生簡介
(Get Rating)
(獲取評級)
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR.
強生及其子公司在全球範圍內研發、製造和銷售醫療保健領域的各種產品。該公司的消費者健康部門提供Johnson‘s和AVEENO Baby品牌的嬰兒護理產品；Listerine品牌的口腔護理產品；AVEENO，Clean&Clear，Dr.
Featured Stories
專題報道
- Get a free copy of the StockNews.com research report on Johnson & Johnson (JNJ)
- Time to Hit Up Hasbro Stock for the Holiday Season
- Should Proctor and Gamble be a Staple in Your Portfolio?
- 3 Fundamentally Sound Mid-Caps to Keep on the Watch List
- Leveraged ETFs, A Bad Investment But Great for Trading
- Should Investors Raise a Glass to Boston Beer Company?
- 免費獲取斯托克新聞網關於強生(JNJ)的研究報告
- 是時候為假日季大漲孩之寶股票了
- 寶潔應該成為你投資組合中的主打產品嗎？
- 3個基本面穩健的中型股將繼續留在觀察名單上
- 槓桿ETF是一種糟糕的投資，但對交易有利
- 投資者應該向波士頓啤酒公司舉杯嗎？
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.
接受《強生日報》的新聞和評級-在下面輸入您的電子郵件地址，即可通過MarketBeat.com的免費每日電子郵件時事通訊接收對強生及相關公司的最新新聞和分析師評級的每日摘要。
譯文內容由第三人軟體翻譯。
